• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA SRL INSPIRE 8F M HOLLOW FIBER OXYGENATOR WITH INTEGRATED ARTERIAL FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA SRL INSPIRE 8F M HOLLOW FIBER OXYGENATOR WITH INTEGRATED ARTERIAL FILTER Back to Search Results
Catalog Number 03705
Device Problem Increase in Pressure (1491)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/22/2021
Event Type  malfunction  
Manufacturer Narrative
Patient information was not provided.The inspire 8f m hollow fiber oxygenator is a non-sterile device assembled into a sterile convenience pack (item in00983 de bad neustadt) that is not distributed in the usa.The expiration date refers to the sterile finished product into which the oxygenator was assembled.As the sterile convenience pack is not distributed in usa, the udi number is not applicable.The complained inspire 8f m hollow fiber oxygenator is a non-sterile component assembled into a convenience pack that is not distributed in the usa.The standalone oxygenator (catalog number 050703) is registered in the usa (510(k) number: k180448).The device manufacture date refers to manufacture date of the sterile, finished convenience pack into which the oxygenator was assembled.Sorin group italia manufactures the inspire 8f m hollow fiber oxygenator.The incident occurred in bad (b)(6).A review of the dhr did not identify any deviations or non-conformities relevant to the reported issue.If any additional information pertinent to the reported event is obtained, it will be provided in a supplemental report.
 
Event Description
The inlet pressure increase after about 1h over 600mmhg; pump stops; delta p was 550mmhg, customer change to a other hlm.
 
Event Description
See intial report.
 
Manufacturer Narrative
Livanova received report of high-pressure excursion event developed across inspire oxygenator 8f during surgery.Medical team elected to change-out the device (operation lasted more than 3 minutes) and procedure was completed without any patient impact.Manufacturing records were verified, and complaint history was reviewed: claimed device was released as conform according to specifications and no further similar issues were ever reported for batch concerned out of 240 total manufactured units sold worldwide, this excluding a systematic quality problem lot-related.Involved unit was returned to livanova facility for investigation after decontamination process.The device was found clogged, with visible traces of blood inside fiber bundle.To remove observed traces, blood compartment was gently flushed with demineralized water and dried with compressed air.During rinsing phase, thick blood was ejected from purge and arterial outlet ports.Upon completion of washing phase, functional test with bovine blood was carried out.Claimed device was tested as per design specifications: according to test results, returned unit was found to be properly working without any performance deviation identified.The measured p values were aligned with the acceptable range of values prescribed within product specifications as per reported blood parameters test conditions based on investigation results, any product malfunction was excluded.The necessary cleaning of the unit prior to functionally testing the device in livanova laboratory most likely removed any cellular deposition and thus restored it to pre-clinical conditions.The claimed high transmembrane oxygenator pressure gradient, not reproduced during lab testing but confirmed by pump-sheet analysis, was reasonably assigned to the increase of hydraulic resistance as a result of undesired cellular activation associated with platelet adhesion and fibrin layer deposition inside the oxygenators.This type of event is a multi-factorial phenomenon possibly triggered by a combination of clinical procedure, therapies (e.G.Anticoagulant prescription, heparin composition and priming composition) and patient-specific health conditions.The risk in the acceptable region.No specific action was currently deemed necessary.Livanova will maintain monitoring the market.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRE 8F M HOLLOW FIBER OXYGENATOR WITH INTEGRATED ARTERIAL FILTER
Type of Device
OXYGENATOR
Manufacturer (Section D)
SORIN GROUP ITALIA SRL
strada statale 12 nord, 86
mirandola, modena
MDR Report Key11692551
MDR Text Key265360329
Report Number9680841-2021-00010
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date01/26/2024
Device Catalogue Number03705
Device Lot Number2102030001
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/22/2021
Initial Date FDA Received04/20/2021
Supplement Dates Manufacturer Received07/09/2021
Supplement Dates FDA Received08/03/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Weight130
-
-